It’s not over The current rebound is already reflected in an “upward recovery in new hospitalizations and critical care admissions”
Bivalent Covid-19 vaccines from Moderna and Pfizer BioNTech for the over 60s, target the original strain and the Omicron variant, available at the Hancy Vaccination Center, Nice FRANCE – 24/10/2022//SYSPEO_sysA039/Credit:SYSPEO/SIPA/2210241415/Credit:SYSPEO/SIPA/2210241423 — SYSPEO/SIPA
The lull that followed the autumn wave is over. The Covid-19 epidemic is on the rise again, according to the health agency. public, whereas the hospital context already has tense, between bronchiolitis and the onset of the flu. The last week has been marked by a “resumption of circulation” of the coronavirus and an increase in hospitalizations, summarized Health public France, in its weekly assessment of the epidemic.
It is currently difficult to obtain precise details of the number of cases in France, due to a social movement by biology laboratories. But the data transmitted by the pharmacies bear witness to a resumption of cases. The current rebound is already reflected; by a “ the rise in new hospitalizations and critical care admissions,” after “four weeks of decline” public France. Last week, 4,210 people were hospitalized for a diagnosis of Covid-19, an increase of 6%. If the total number of hospitalized patients (less than 19,000) remains significantly below the highest levels observed this year, this recovery risks putting a strain on the population. testing a health system in situation already; very difficult.
The bronchiolitis epidemic, which mainly affects babies, has been on an unprecedented scale for ten years. And that of seasonal flu, although not yet declared, is announced earlier than at the beginning of the year. the usual and raised fears of the impact of a “tripledemic”. In this context, while recalling the importance of barrier gestures such as wearing a mask in closed and very busy places, Santéé public France encourages the French to get started day of their anti-Covid vaccination. Since the beginning of October, this has provided for a booster dose for people with risk, which include all those over 60 years old.
Among 60-79 year olds, only 31.2% are considered protected by vaccination (vaccination of less than 6 months); in people aged 80 and over, 12% (vaccination less than 3 months old), according to data from the health agency as of November 21. As for vaccines adapted to the Omicron variant, 6.1% of 60-79 year olds and 7.9% of people aged 80 and over received a booster with this type of serum.